These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 26812610)

  • 21. Co-Delivery of Epirubicin and siRNA Using Functionalized Mesoporous Silica Nanoparticles Enhances In vitro and In vivo Drug Efficacy.
    Hanafi-Bojd MY; Jaafari MR; Ramezanian N; Abnous K; Malaekeh-Nikouei B
    Curr Drug Deliv; 2016; 13(7):1176-1182. PubMed ID: 26718488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Daidzein-loaded nanostructured lipid carriers-PLGA nanofibers for transdermal delivery.
    Song J; Fan X; Shen Q
    Int J Pharm; 2016 Mar; 501(1-2):245-52. PubMed ID: 26851353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioavailability enhancement, Caco-2 cells uptake and intestinal transport of orally administered lopinavir-loaded PLGA nanoparticles.
    Joshi G; Kumar A; Sawant K
    Drug Deliv; 2016 Nov; 23(9):3492-3504. PubMed ID: 27297453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro uptake evaluation in Caco-2 cells and in vivo results in diabetic rats of insulin-loaded PLGA nanoparticles.
    Reix N; Parat A; Seyfritz E; Van der Werf R; Epure V; Ebel N; Danicher L; Marchioni E; Jeandidier N; Pinget M; Frère Y; Sigrist S
    Int J Pharm; 2012 Nov; 437(1-2):213-20. PubMed ID: 22940208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A co-delivery system based on paclitaxel grafted mPEG-b-PLG loaded with doxorubicin: preparation, in vitro and in vivo evaluation.
    Li Q; Lv S; Tang Z; Liu M; Zhang D; Yang Y; Chen X
    Int J Pharm; 2014 Aug; 471(1-2):412-20. PubMed ID: 24905776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AS1411 aptamer tagged PLGA-lecithin-PEG nanoparticles for tumor cell targeting and drug delivery.
    Aravind A; Jeyamohan P; Nair R; Veeranarayanan S; Nagaoka Y; Yoshida Y; Maekawa T; Kumar DS
    Biotechnol Bioeng; 2012 Nov; 109(11):2920-31. PubMed ID: 22615073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted delivery of epirubicin to tumor-associated macrophages by sialic acid-cholesterol conjugate modified liposomes with improved antitumor activity.
    Zhou S; Zhang T; Peng B; Luo X; Liu X; Hu L; Liu Y; Di D; Song Y; Deng Y
    Int J Pharm; 2017 May; 523(1):203-216. PubMed ID: 28336455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced bioavailability and intestinal uptake of Gemcitabine HCl loaded PLGA nanoparticles after oral delivery.
    Joshi G; Kumar A; Sawant K
    Eur J Pharm Sci; 2014 Aug; 60():80-9. PubMed ID: 24810394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colon-targeted delivery of cyclosporine A using dual-functional Eudragit
    Naeem M; Bae J; Oshi MA; Kim MS; Moon HR; Lee BL; Im E; Jung Y; Yoo JW
    Int J Nanomedicine; 2018; 13():1225-1240. PubMed ID: 29535519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation and evaluation of tumour microenvironment response multistage nanoparticles for epirubicin delivery and deep tumour penetration.
    Dai J; Han S; Ju F; Han M; Xu L; Zhang R; Sun Y
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):860-873. PubMed ID: 29771149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Annealing as a tool for the optimization of lyophilization and ensuring of the stability of protein-loaded PLGA nanoparticles.
    Fonte P; Lino PR; Seabra V; Almeida AJ; Reis S; Sarmento B
    Int J Pharm; 2016 Apr; 503(1-2):163-73. PubMed ID: 26972381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and evaluation of long-circulating nanoparticles loaded with betulinic acid for improved anti-tumor efficacy.
    Saneja A; Kumar R; Singh A; Dhar Dubey R; Mintoo MJ; Singh G; Mondhe DM; Panda AK; Gupta PN
    Int J Pharm; 2017 Oct; 531(1):153-166. PubMed ID: 28823888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Engineering PLGA nano-based systems through understanding the influence of nanoparticle properties and cell-penetrating peptides for cochlear drug delivery.
    Cai H; Liang Z; Huang W; Wen L; Chen G
    Int J Pharm; 2017 Oct; 532(1):55-65. PubMed ID: 28870763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation and in vitro evaluation of meloxicam-loaded PLGA nanoparticles on HT-29 human colon adenocarcinoma cells.
    Şengel-Türk CT; Hasçiçek C; Dogan AL; Esendagli G; Guc D; Gönül N
    Drug Dev Ind Pharm; 2012 Sep; 38(9):1107-16. PubMed ID: 22348284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Transport of PLGA nanoparticles across Caco-2/HT29-MTX co-cultured cells].
    Wen Z; Li G; Lin DH; Wang JT; Qin LF; Guo GP
    Yao Xue Xue Bao; 2013 Dec; 48(12):1829-35. PubMed ID: 24689242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel flavonoid-based biodegradable nanoparticles for effective oral delivery of etoposide by P-glycoprotein modulation: an in vitro, ex vivo and in vivo investigations.
    Fatma S; Talegaonkar S; Iqbal Z; Panda AK; Negi LM; Goswami DG; Tariq M
    Drug Deliv; 2016; 23(2):500-11. PubMed ID: 24937381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound.
    Li Z; Huang H; Huang L; Du L; Sun Y; Duan Y
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28406431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uptake mechanism of furosemide-loaded pegylated nanoparticles by cochlear cell lines.
    Youm I; Youan BB
    Hear Res; 2013 Oct; 304():7-19. PubMed ID: 23747541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surface functionalized mesoporous silica nanoparticles as an effective carrier for epirubicin delivery to cancer cells.
    Hanafi-Bojd MY; Jaafari MR; Ramezanian N; Xue M; Amin M; Shahtahmassebi N; Malaekeh-Nikouei B
    Eur J Pharm Biopharm; 2015 Jan; 89():248-58. PubMed ID: 25511563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Poly-(Lactic-co-Glycolic) Acid Nanoparticles for Synergistic Delivery of Epirubicin and Paclitaxel to Human Lung Cancer Cells.
    Sharma N; Kumari RM; Gupta N; Syed A; Bahkali AH; Nimesh S
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32947799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.